Macpherson Edward Clouston Acquires 50,000 Shares of MIRA
Insider Macpherson Edward Clouston recently bought 50,000 shares of MIRA.
Key Points
- Macpherson Edward Clouston bought 50,000 shares of MIRA on June 12, 2026.
- MIRA shares traded at approximately $0.93 at the time of the transaction.
- Vanguard Capital Management and BlackRock, Inc. also hold significant positions in MIRA.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Macpherson Edward Clouston recently purchased 50,000 shares of MIRA on June 12, 2026. The transaction was not part of a pre-planned trading program. At the time of the purchase, MIRA shares were trading around $0.93.
Other Institutional Activity in MIRA
Vanguard Capital Management LLC made a significant move by acquiring 693,912 shares of MIRA, valued at approximately $742,486. Geode Capital Management, LLC also increased its holdings by 18,012 shares, bringing its total to 290,890 shares worth about $311,251. Meanwhile, BlackRock, Inc. added 2,577 shares, ending with 112,346 shares valued at $120,210. On the other hand, Suncoast Equity Management reduced its position by 12,644 shares, leaving it with 90,645 shares valued at $96,990.
Insider Buying and Selling at MIRA Pharmaceuticals, Inc.
On June 12, 2026, several insiders including Macpherson Edward Clouston, Del Giudice Matthew Paul, Whalen Matthew Pratt, and Shekhat Denil Nanji each purchased 50,000 shares of MIRA. These transactions were not part of any pre-planned trading programs. Earlier, on December 17, 2025, CEO and Chairman Erez Aminov made a substantial acquisition of 3,155,170 shares.
Bottom Line
Insider purchases like those by Macpherson Edward Clouston can signal confidence in MIRA's prospects. The activity among institutional investors, including Vanguard Capital Management and BlackRock, Inc., also highlights interest in the company. While insider and institutional moves provide insights, they do not necessarily predict future performance.
Get MIRA Pharmaceuticals, Inc. alerts
New 13F filings, insider trades, and analyst moves on $MIRA, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.